Honeywell International Inc. Sells 61100 Shares of Celgene Corporation (CELG)

The Firm operates through three divisions: Northeast, South/West and Midwest. It has a 34.28 P/E ratio.

Shaker Investments LLC OH increased its stake in Celgene Corporation (NASDAQ:CELG) by 140.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Commerzbank Aktiengesellschaft sold 12,989 shares as Celgene Corp (CELG)’s stock declined 3.49%. Edge Wealth Management LLC now owns 15,920 shares of the biopharmaceutical company’s stock valued at $1,979,000 after buying an additional 1,518 shares in the last quarter. Celgene Corp now has $96.93 billion valuation. The stock rose 1.58% or $1.93 reaching $124.29. Stanford Investment Group Inc. now owns 1,364 shares of the biopharmaceutical company’s stock worth $158,000 after buying an additional 68 shares during the last quarter. It is down 17.00% since June 20, 2016 and is uptrending. It has outperformed by 3.59% the S&P500. It also reduced Harman International (NYSE:HAR) stake by 44,634 shares and now owns 587,660 shares. General Electric Co (NYSE:GE) was reduced too.

Celgene Corporation (NDAQ:CELG) was upped by Leerink Swann from a “Market Perform” rating to a more respectable “Outperform” rating in an analyst note revealed to investors and clients earlier today. Howe Rusling accumulated 10 shares or 0% of the stock. This translates into $1.28 billion profit for CELG giving the stock a 19.15 P/E. The biopharmaceutical company reported $1.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.21.

Celgene Corporation earned a news sentiment score of 0.38 on Alpha One’s scale. Its up 0.28, from 1.45 in 2016Q3. It dropped, as 57 investors sold CELG shares while 470 reduced holdings. Bank of Montreal Can raised its position in Celgene Corporation by 149.8% in the first quarter. California Pub Employees Retirement Systems holds 1.84 million shares or 0.36% of its portfolio. ING Groep NV now owns 183,655 shares of the biopharmaceutical company’s stock worth $21,475,000 after buying an additional 23,019 shares during the last quarter. Putnam Ltd Limited Liability Company accumulated 3.46 million shares. Ww Asset Inc, a Michigan-based fund reported 70,956 shares. Tcw Group invested in 2.10 million shares or 1.83% of the stock. Hanson & Doremus Management holds 200 shares or 0% of its portfolio. Pennsylvania Company invested 0.32% of its portfolio in Celgene Corporation (NASDAQ:CELG). 5,150 are owned by Spc. They expect $1.62 EPS, up 26.56% or $0.34 from last year’s $1.28 per share. Massachusetts Service Communication Ma holds 5.52 million shares or 0.31% of its portfolio. Comerica Bank & Trust holds 0.26% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 279,408 shares. First Manhattan stated it has 140,295 shares. 7,500 shares were sold by CASEY MICHAEL D, worth $911,625. On Wednesday, March 1 VESSEY RUPERT sold $497,672 worth of Celgene Corporation (NASDAQ:CELG) or 4,000 shares. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Thursday, January 7 by Suntrust Robinson. The stock of Celgene Corporation (NASDAQ:CELG) has “Hold” rating given on Wednesday, November 9 by Standpoint Research. Therefore 75% are positive. Celgene Corporation had 42 analyst reports since July 21, 2015 according to SRatingsIntel. The stock now has a consensus rating of “Buy” and a consensus target price of $139.49. BTIG Research reaffirmed a “buy” rating and issued a $138.00 target price on shares of Celgene Corporation in a research report on Wednesday, May 24th. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by UBS on Friday, July 24. Madison Hldg holds 0.18% in Celgene Corporation (NASDAQ:CELG) or 79,764 shares. The company was maintained on Thursday, June 1 by Mizuho. Barrett Asset Ltd Liability Corporation has invested 1.01% in Celgene Corporation (NASDAQ:CELG).

COPYRIGHT VIOLATION WARNING: “Exane Derivatives Reduces Stake in Celgene Corporation (CELG)” was originally published by Stock Observer and is the sole property of of Stock Observer. About 86,066 shares traded. It is down 92.67% since June 19, 2016 and is uptrending. It has outperformed by 15.20% the S&P500. Stifel Financial holds 1.18M shares. Following the completion of the sale, the director now owns 73,109 shares of the company’s stock, valued at $9,053,087.47. Benjamin F Edwards invested in 4,271 shares. The New York-based Goldentree Asset Management Lp has invested 3.55% in the stock. Cullinan Assoc, a Kentucky-based fund reported 61,418 shares. The legal version of this article can be read at https://baseballnewssource.com/markets/celgene-corporation-celg-given-a-148-00-price-target-by-oppenheimer-holdings-inc-analysts-updated/981717.html. During the same quarter in the prior year, the firm earned $1.32 EPS. The Morgens Waterfall Vintiadis & Co Inc holds 40,900 shares with $4.73M value, up from 30,000 last quarter. The lowest target is $14.0 while the high is $23.0. PENN was included in 4 notes of analysts from October 28, 2016. Robert W. Baird maintained the stock with “Outperform” rating in Tuesday, May 23 report. JP Morgan downgraded Penn National Gaming, Inc (NASDAQ:PENN) on Thursday, January 5 to “Neutral” rating.

Receive News & Ratings for Celgene Corporation Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Celgene Corporation and related companies with MarketBeat.com’s FREE daily email newsletter.